Purchases and Sales Made in Q4 2022 in Harvard Bioscience Inc (HBIO)
This table provides information about the institutional ownership of Harvard Bioscience Inc (HBIO) during Q4 2022. The information is specifically focused on institutions that hold shares of HARVARD BIOSCIENCE INC.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 14, 2023
Q4 2022
|
Bridgeway Capital Management, LLC
Houston, TX |
SELL
|
- |
-49.6K- 18.17% |
$105K - $142K
|
223K
$478K
|
|
|
Feb 14, 2023
Q4 2022
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
SELL
|
- |
-60.5K- 28.36% |
$128K - $173K
|
153K
$327K
|
|
|
Feb 13, 2023
Q4 2022
|
Royce & Associates LP
|
SELL
|
- |
-73.4K- 4.9% |
$156K - $210K
|
1.42M
$3.05M
|
|
|
Feb 10, 2023
Q4 2022
|
Globeflex Capital L P
San Diego, CA |
SELL
|
- |
-94.5K- 42.23% |
$200K - $270K
|
129K
$277K
|
|
|
Feb 14, 2023
Q4 2022
|
Ergoteles LLC
New York, NY |
SELL
|
- |
-98.7K- 66.9% |
$209K - $282K
|
48.8K
$105K
|
|
|
Feb 13, 2023
Q4 2022
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
SELL
|
- |
-117K- 13.76% |
$248K - $335K
|
734K
$1.57M
|
|
|
Feb 14, 2023
Q4 2022
|
Jacobs Levy Equity Management, Inc
Florham Park, NJ |
SELL
|
- |
-125K- 47.65% |
$266K - $358K
|
138K
$295K
|
|
|
Feb 02, 2023
Q4 2022
|
Monarch Partners Asset Management LLC
|
SELL
|
- |
-187K- 23.39% |
$397K - $536K
|
614K
$1.31M
|
|
|
Feb 10, 2023
Q4 2022
|
Vanguard Group Inc
Valley Forge, PA |
SELL
|
- |
-280K- 18.23% |
$595K - $802K
|
1.26M
$2.69M
|
|
|
Feb 13, 2023
Q4 2022
|
Portolan Capital Management, LLC
Boston, MA |
SELL
|
- |
-288K- 21.44% |
$610K - $823K
|
1.05M
$2.26M
|
|
|
Feb 13, 2023
Q4 2022
|
Black Rock Inc.
New York, NY |
SELL
|
- |
-289K- 24.22% |
$613K - $827K
|
904K
$1.93M
|